The Medicare GLP-1 Bridge: Three Reasons Prior Authorizations Get Denied

Your patient has been asking about Wegovy for two years. She is on Medicare, she does not have diabetes, and every previous conversation ended the same way. Then on July 1, 2026, that changed.

The Medicare GLP-1 Bridge opened a coverage pathway for GLP-1 medications prescribed for weight management. It is a real pathway with a $50 monthly copay, and it runs through December 31, 2027.

It also has criteria specific enough that a thorough, well-written note can still produce a denied request. Three things account for most preventable denials, and all three are avoidable if you know about them before you send the prescription. This article covers what the program is, who qualifies, and those three failure points, so your first submission is your only submission.